...

 
Cannvas.Me
Sign Up For Free
A third identified receptor in the human endocannabinoid system was studied last year to focus on the potential of the “GPR55 Receptor” and its connection with medical cannabis.

The endocannabinoid system is the system in the body that interacts with cannabis properties to provide the promising health benefits that have been experienced. It holds cannabinoid receptors, which are specialized protein molecules that interact with the cannabis. Since the 1990s, scientists have known about the receptors CB1 and CB2, but research has come short on the others. 

The team at the University of Washington at Seattle who performed the study found a role for the receptor in the use of CBD to treat Dravet Syndrome, a rare form of epilepsy in Children. They stated that they saw potential to “extend the scope of CBD treatment to autistic-like behaviors, and provide initial mechanistic insights into CBD’s therapeutic actions”. 

The study can be found in the Proceedings of the National Academy of Sciences (PNAS)

Source: https://cannabisnow.com/gpr55-the-third-cannabinoid-receptor/

 

This article is now marked as read.

Was this article helpful?

Review this article to help us continue creating and sharing relevant content.

Please note it may take up to two business days for reviews to be validated and published.

Reviews

Review this article to help us continue creating and sharing relevant content.

Write Review

Would you like to
make this review public?

Please disable your ad blocker to avoid issues using social plugins on Cannvas.Me. Thanks.
Close